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SUMMARY: The present study aims to produce low cost sophorolipids, and to evaluate their potential hypocho-
lesterolemic impact. Sophorolipids were produced by Candida bombicola grown on safflower oil cake, extracted 
by methanol followed by ethyl acetate with a yield of 24.4 and 48.3 g·100 g−1 mixed substrate, respectively. Their 
structure was confirmed by FTIR and 1H NMR and proven to be safe when subjected to an acute toxicity test. 
A biological experiment was done on 42 male albino rats classified into six groups for 4 weeks following an induc-
tion period for hypercholesterolemia of 8 weeks. The two extracts and their mixture were examined for their hypo-
cholesterolemic effect compared to rosuvastatin. The results revealed a reduction in total cholesterol, low density 
lipoprotein cholesterol, atherogenic index, liver transaminases’ activity and malondialdehyde. They also revealed 
an elevation in high density lipoprotein cholesterol and antioxidant enzymes which was more efficient than rosu-
vastatin. Histopathological examination confirmed these results. In conclusion, the newly isolated sophorolipids 
are powerful hypocholesterolemic compounds which are even more efficient and safer than rosuvastatin.
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RESUMEN: Efecto hipocolesterolémico de soforolípidos recién aislados producidos por la conversión microbiana 
de la torta de aceite de cártamo en ratas alimentadas con una dieta rica en grasas y colesterol. El presente estudio 
tiene como objetivo producir soforolípidos de bajo costo, evaluando su potencial impacto hipocolesterolémico. 
Los soforolípidos fueron producidos por Candida bombicola cultivada en torta de aceite de cártamo, extraída con 
metanol seguido de acetato de etilo con un rendimiento de 24,4 y 48,3 g·100 g−1 de sustrato mixto, respectiva-
mente. Su estructura fue confirmada por FTIR y 1H RMN y demostró ser segura cuando se sometió a prueba de 
toxicidad aguda. Un experimento biológico se realizó con 42 ratones albinos machos clasificados en seis grupos, 
durante 4 semanas, después de un período de inducción al hipercolesterolemia de 8 semanas. Se examinaron los 
dos extractos y su mezcla para determinar su efecto hipocolesterolémico en comparación con rosuvastatina. 
Los resultados revelaron una reducción en el colesterol total, el colesterol de lipoproteínas de baja densidad, el 
índice aterogénico, la actividad de las transaminasas hepáticas y el malondialdehído, mientras que mostraron una 
elevación del colesterol de lipoproteínas de alta densidad y de las enzimas antioxidantes más eficientemente que 
la rosuvastatina. El examen histopatológico confirmó estos resultados. En conclusión, los soforolípidos recién 
aislados son potentes compuestos hipocolesterolémicos aún más eficientes y más seguros que la rosuvastatina.
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1. INTRODUCTION
Atherosclerosis is the principal contributor to 
the pathogenesis of myocardial and cerebral infarc-
tions. It is known to be one of the leading causes of 
morbidity and mortality worldwide (Uhegbu et al., 
2013). The etiology of atherosclerosis is multi-fac-
torial; hypercholesterolemia is one of these factors 
(Jegadeesh et al., 2014).
Most of the commonly used hypocholesterol-
emic drugs have undesirable side effects. Statins as 
a new generation of hypocholesterolemic drugs are 
widely used to lower cholesterol, preventing the risk 
of coronary heart disease. They work as mevalon-
ate pathway inhibitors, thus blocking cholesterol 
synthesis. The most common side effect of statins 
is related to the depletion of the coenzyme Q10 
which is used for energy production by body cells 
(Graveline, 2015). Consequently, there has been an 
increased interest in creating natural products for 
the production of hypocholesterolemic drugs with 
lower adverse effects.
Amphiphilic compounds have been found to 
have interesting applications, due to their ability to 
form surface and emulsifying activities. They are 
classified as bio-surfactants, and used in medicine 
for their antimicrobial, antiviral and potential anti-
cancer activities. Different types of bio-surfactants 
have been reported, such as glycolipids, lipopep-
tides, polysaccharide-protein complexes, phospho-
lipids, fatty acids and neutral lipids (Wang et al., 
2007; Rashad et al., 2014a). This wide range in the 
chemical structure of different groups of bio-sur-
factants allowed them to be reasonable for exert-
ing diverse properties and physiological functions. 
Furthermore, the characterization of being effective 
at extreme pH values or temperatures, lower toxicity 
and higher biodegradability make bio-surfactants 
suitable and favorable over the chemical surfac-
tants in environmental applications (Rashad et al., 
2014b).
Industrial food wastes are cheap and good 
sources of nutrients and minerals. They can be used 
as a substrate for the production of low priced bio-
active materials (Daverey and Pakshirajan, 2009). 
The industry of edible fats and lipids generates great 
amounts of oil waste, for example fatty acids and 
oil cakes. Plants constitute about 75% of the world-
wide production of oils and fats (Haba et al., 2000); 
one of these wastes is safflower oil cake which is a 
residue from the pressed seeds after oil extraction. 
Previously sunflower oil cake has been employed 
for the production of bio-surfactants (Rashad et al., 
2014a).
Bio-surfactants are produced by microorganisms 
such as Bacillus subtilis, Renibacterium salmonina-
rum, Pseudomonas aeruginosa, Pseudomonas putida, 
Pseudomonas chlororaphis, Candida bombicola and 
Candida apicola. They contain hydrophilic and 
hydrophobic moieties, which are essential for the 
survival of the microorganisms by acting as bio-
cide agents, facilitating microbe-host interactions 
or facilitating nutrient transporting (Van Hamme 
et  al., 2006; Rashad et al., 2014a). Sophorolipids 
(SLs) are a sort of extracellular glycolipid bio- 
surfactant and they are produced by yeasts such as 
Candida bombicola. They consist of one sophorose 
molecule attached to one hydroxyl fatty acid by one 
or two cross lines (Price et al., 2012).
Having the ability to emulsifying fats, SLs are 
expected to exert a role in cholesterol metabolism in 
humans. Therefore, this study aims to produce low 
cost SL compounds using C. bombicola cultivated 
on safflower oil cake (which is an industrial waste) 
using a solid-state fermentation (SSF) technique. 
Also, to investigate their possible hypocholesterol-
emic effects on hypercholesterolemic rats compared 
to one of the commonly used statin family mem-
bers; rosuvastatin.
2. MATERIALS AND METHODS
2.1. Materials
2.1.1. Substrates
Safflower seeds (CarthamusTinctoriusL.) namely 
Giza 1 were obtained from the local market (Cairo, 
Egypt). The safflower seeds were pressed with labo-
ratory-type Carver hydraulic press under 10.000 Ib 
in-2 pressure for 1 h at room temperature according 
to (Üstun et al., 1990), then the safflower oil cake 
residue was collected, frozen and kept at -4 °C until 
analysis. Crude soybean oil was obtained from the 
Food Technology Research Institute, Soy Processing 
Centre, Agriculture Research Centre, (Giza, Egypt).
2.1.2. Yeast strain
Candida bombicola NRRL Y-17069 was obtained 
from the Agricultural Research Service, (Peoria, 
Illinois, USA). The culture was kept in a stock slant 
medium (Wickerham, 1951).
2.1.3. Animal Experiment
Most of the ingredients used for preparation of 
the diet (Table 1) that was introduced to the rats 
were obtained from the local market, while, casein 
was obtained from Scerma Co., (France). The 
salt and vitamin mixtures used were of analytical 
grade and obtained from Fluka (Germany) and 
BDH (England) Chemical Companies. Cellulose 
and cholesterol powder were obtained from Fine-
Chem Limited (Mumbai, India). The hypocholes-
terolemic drug (rosuvastatin) was obtained from 
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IPR Pharmaceutical Inc., (Egypt) under license of 
Puerto Rico (AstraZeneca), (UK).
The kits used for the determination of  blood 
hemoglobin (Hb), plasma glucose, plasma cata-
lase, erythrocyte (RBCs) glutathione peroxidase 
(GPx) and RBCs superoxide dismutase (SOD) 
were obtained from the Biodiagnostic Company, 
(Egypt). The kit used for the determination of 
plasma triacylglycerols (TG) was obtained from 
the Stanbio Laboratory Company, (USA). The 
kits used for the estimation of  plasma total cho-
lesterol (TC), high density lipoprotein cholesterol 
(HDL-C), urea, and creatinine were purchased 
from Chronolab Systems, (Barcelona, Spain). The 
kits used for the determination of  plasma aspartate 
aminotransferase (AST) and alanine aminotrans-
ferase (ALT) were obtained from the Salucea Co., 
(Netherlands). The chemicals used for the deter-
mination of  plasma lipid peroxide product (malo-
ndialdehyde: MDA); the thiobarbituric acid (TBA) 
and the trichloroacetic acid (TCA) were obtained 
from the Merck (Germany) and BDH (England) 
Companies, respectively.
The animals used in the biological experiment 
were Sprague Dawley male albino rats. They were 
obtained from the Central Animal House, National 
Research Centre, (Egypt). The study protocol was 
approved by Scientific Committee at the National 
Research Centre (NRC, Egypt). Animal experi-
ments were conducted according to the guidelines 
of animal care and ethics committee of the NRC 
(Approval no: 15118).
2.2. Methods
2.2.1. Inoculum preparation
The inoculum was prepared by transfer-
ring a  loop full of a stock culture (7 days old) of 
C.  bombicola NRRL Y-17069 to a 50 mL sterile 
inoculum medium (Wickerham, 1951), which was 
then incubated at 30 °C, 180 rpm for 24h.
2.2.2. Cultivation conditions
The SSF medium was prepared according to 
the  method of  Rashad et al. (2014a) with some 
modifications as follows: 5 g of  safflower oil 
cake waste, 5 g of  soybean oil and 4 mL of  nutri-
ents solution consisting of  (g·L−1) NH4NO3, 1.0; 
K2HPO4, 2.55; NaH2PO4, 0.15; MgSO4.7H2O, 
0.5; CaCl2.2H2O, 0.1; MnSO4.H2O, 0.02; peptone, 
1.0. Final pH was adjusted to 7.8. One ml of  the 
overnight culture (1x 108 cell ml−1) was mixed for 
seeding thoroughly to the above sterilized media 
(121  °C, 20 min) for 14 days and incubated in 
static condition at 28–30 °C.
2.2.3. Extraction of SLs
2.2.3.1. Methanol Extraction
The crude SLs were isolated according to Rashad 
et al. (2014a) by adding 45 ml of methanol to one 
volume of the fermented solid waste and the mix-
ture was shaken at 90 strokes min−1 for 60 min with 
a reciprocal shaker (New Brunswick Scientific, 
USA). The crude extract was then filtered through 
Whatman no. 40 filter paper to obtain the methanol 
extract (ME).
2.2.3.2. Re-extraction by ethyl acetate
The re-extraction was made according to 
Rashad et al. (2014a) by re-extracting the resid-
ual  fermented substrates with 45 mL of  ethyl 
acetate and shaking at 90 strokes·min−1 for 60 min 
with a reciprocal shaker, filtered by Whatman 
40 filter paper to obtain the second ethyl acetate 
extract (EAE).
2.2.4. Fourier transform infrared spectroscopy 
(FTIR)
The infrared (IR) spectrum (from 400 to 4000 
wave numbers, cm−1) of SLs extracts were recorded 
using a KBr pellet in Nicolet Impact 6100 FTIR 
spectrophotometer JASCO, USA.
2.2.5. 1H NMR spectra analysis
The NMR spectra were recorded on a Varian 
Mercury VX-300 NMR spectrometer. 1H spectra 
were run at 300 MHz in deuterated chloroform 
(CDCl3). Chemical shifts are quoted in d and were 
related to those of the solvents.
Table 1. Composition of  the diets of  control rats 
(g/100g) diet
Ingredients Amount (g)
Casein* 21.9
Sucrose 5
Cellulose 4
Corn oil 8
Salt mixture (AIN-93 )* 3.5
Vitamin mixture (AIN-93 )* 1
Choline bitartrate 0.25
L- Cystine 0.18
Corn starch 56.17
*Protein content of  casein was estimated as 54.6%. Salt 
and  vitamin mixtures were prepared according to Reeves 
et al., 1993.
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2.2.6. Biological Evaluation
2.2.6.1. Acute toxicity test
First, the obtained extracts were subjected 
to an acute lethal toxicity test (LD50) to evaluate 
their safety. This was done according to Goodman 
et  al., (1980). A number of  84 Swiss male albino 
mice were included. They were divided into 14 
groups of  6 mice each. Two sets of  groups were 
included, seven groups for the methyl extract (ME) 
and seven groups for the EAE. Then, progressively 
increasing oral doses from each extract calculated 
as g/Kg B. wt. were given to the groups of  each set 
as follows; 1, 2, 4, 6, 8, 10, 12. Then, the 24-hour 
mortality counts of  the animals were observed and 
recorded.
2.2.6.2. Formulation of the diet
The standard control diet was prepared accord-
ing to Reeves et al. (1993) as shown in Table 1. The 
high-cholesterol and high-fat diets was prepared 
by adding 2% pure cholesterol, 0.25% bile salts 
and 20% fat to the standard diet at the expense of 
starch.
This experiment was done on 42 male Sprague 
dawley albino rats of body weight from 100 to 120 g. 
Each rat was housed individually in a separate cage 
in an air conditioned room regulated at a tempera-
ture of 25 °C. Food and water were administered to 
the rats ad-libitum. A group of 7 rats was separated 
from the whole group to serve as a negative control 
group (control -ve) and fed the standard control diet 
(Table 1). The rest of the rats were fed a high-fat 
and high-cholesterol diet (HFHC) containing 200g 
lard /Kg diet, 20g cholesterol/Kg diet and 0.25% bile 
salts for eight weeks to induce hypercholesterolemia 
(Mahmoud et al., 2011). Then, the hypercholester-
olemic rats were divided into 5 groups of 7 rats each 
as follows:
Group 2: Hypercholesterolemic rats fed the 
HFHC diet and given an oral dose of saline to serve 
as a control positive group (control +ve).
Group 3: Hypercholesterolemic rats fed the 
HFHC diet and given a daily oral dose of rosuv-
astatin (Ros.)10 mg/kg body weight (HFHC+Ros).
Group4: Hypercholesterolemic rats fed the 
HFHC diet and given a daily oral dose of the 
methyl extract (ME) as 200 mg/kg body weight 
(HFHC+ME).
Group5: Hypercholesterolemic rats fed the 
HFHC diet and given a daily oral dose of the EAEas 
200mg/Kg body weight (HFHC+EAE).
Group 6: Hypercholesterolemic rats fed the 
HFHC diet and given a daily oral dose of a mixture 
(Mix.) of ME and EAE (1:1) as 200 mg/Kg body 
weight (HFHC + Mix).
Body weight and daily food consumption were 
followed and recorded. After four weeks, fasting 
blood samples were obtained from the suborbital 
vein under slight diethyl ether anesthesia, sepa-
rated and stored at -70 °C until analysis. The organs 
including liver, heart, kidneys and brain were sep-
arated, weighed and a portion of each organ was 
embedded into 10% formalin solution for histopath-
ological examination.
2.2.7. Biochemical analysis
Blood hemoglobin was determined according 
to Betke and Savelsberg (1950). The antioxidant 
enzymes namely RBCs SOD, plasma catalase 
and  RBCs GPx were estimated according to the 
methods of  Nishikimi et al. (1972), Aebi (1984) 
and Paglia and Valentine (1967), respectively. 
Plasma peroxidation product; MDA was detected 
by the thiobarbituric acid (TBA) assay accord-
ing to the method of  Draper and Hadley (1990). 
Blood glucose was estimated according to the 
method described by Trinder (1969). The activi-
ties of  both ALT & AST were measured accord-
ing to the method of  Henry et al. (1960). Plasma 
urea and creatinine were assessed as described 
by Fawcett and Scott (1960) and Murray (1984), 
respectively.
Lipid parameters were estimated as follows; 
plasma triacylglycerols was assessed as described 
by Scheletter and Nussel (1975). Plasma total cho-
lesterol was determined as described by Meiattini 
et al. (1978). HDL-C was determined according 
to Grove (1979). Low-density lipoprotein choles-
terol (LDL-C) and very-low-density lipoprotein 
cholesterol (VLDL-C) were determined according 
to Warnick et al. (1990) as shown in the following 
equations:
LDL-C = Total cholesterol – (HDL-C+ VLDL-C)
Where, VLDL-C = Triacylglycerols /5
Atherogenic index (A.I.) was calculated as 
described by Dobiasova (2004) according to the 
equation:
A.I. = log (triacylglycerols/ HDL-C).
The concentration of all of the previously men-
tioned biochemical parameters were measured by a 
colorimetric technique using a spectrophotometer 
(Shimadzu UV-2401 PC, Australia).
2.2.8. Histopathological analysis
Specimens from liver, heart, kidney and brain 
were histopathologically examined after being 
cleared in xylol, embedded in paraffin, sec-
tioned at 4–6 micron thickness and stained with 
Heamatoxylin and Eosin. Finally, they were exam-
ined under microscope.
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2.2.9. Statistical analysis
Results were analyzed statistically using the com-
puterized program SPSS version “20”. The one way 
ANOVA test was done followed by the Duncan test. 
Data were represented as mean ± SE. Significance 
was considered at a level of 0.05.
3. RESULTS AND DISCUSSION
Controlling blood cholesterol is important 
for reducing the risk of  developing atherosclero-
sis (Jegadeesh et al., 2014). In fact, although the 
current hypocholesterolemic drugs such as statins 
give good results for lowering cholesterol with 
well-known mechanisms (Rideout et al., 2010), 
the need for alternative drugs is pivotal due to 
some disadvantages of  the current drugs among 
which is the lack of  positive effect on HDL-C 
(Kobayashi et al., 2008). Also, many side effects 
from the use of  statins were detected (Graveline, 
2015) as well as the high cost for the production of 
these synthetic drugs. Consequently, searching for 
natural products with few or no side effects and 
lower cost becomes necessary. SLs as a type of 
bio-surfactants are known to have medical appli-
cation for their health benefits (Price et al, 2012). 
One of  the objectives in this study was to find a 
suitable economic substrate for the production of 
SLs and to examine their ability to lower choles-
terol in the hypercholesterolemic rats. The SSF 
technique was employed with a mixture of  saf-
flower oil cake and crude soybean oil. Extraction 
of  the crude SLs was carried out using methanol 
as the first extraction solvent, which resulted in a 
yield of  24.4 g·100 g−1 mixed substrate, while the 
re-extraction by ethyl acetate from the remaining 
culture gave a higher yield of  SLs (48.3 g·100 g−1 
mixed substrate).
Safflower oil cake and soybean oil mixture with 
the SSF technique was used for the first time in 
the production of  SLs. Previously, safflower oil 
was added as a source of  fatty acids with the liq-
uid fermentation technique for the production of 
SLs by Torulopsis bombicola (Ito and Inoue, 1982). 
Rahman et al. (2002) also used safflower oil and 
soybean oil for the production of  rhamnolipid 
bio-surfactant from Pseudomonas aeruginosa GS9-
119 and DS10-129 using the liquid fermentation 
technique.
Regarding the production process, the yield of 
SLs resulting in this study from the extraction and re-
extraction technique was higher than that obtained 
from previous works (17g·100 g−1and 32.5 g·100 g−1) 
and (4.75 g·100 g−1 and 41.77 g·100 g−1) for the pro-
duction of SLs using sunflower oil cake plus soy-
bean oil or motor oil waste respectively, fermented 
by C. bombicola (Rashad et al, 2014 a and b). Lower 
yield was also reported (23.5 g·100 g−1 dry mat-
ter) for the production of SLs using the SSF of 
sunflower winterization oil cake plus sugar beet 
molasses by Starmerella bombicola ATCC 22214 
(Jiménez-Peñalver et al., 2016). The yield obtained 
in this study was also higher than that produced by 
Parekh and Pandit (2012), who found that the SSF 
of glucose, wheat bran and oleic acid by Starmerella 
bombicola NRRL Y-17069 produce a maximum SL 
yield of 18g per 100g substrate.
The isolated SL compounds (M & EA extracts) 
were identified and characterized by FTIR 
(Figure  1). The obtained data revealed the pres-
ence of  broad bands at 3387 and 3471 cm−1 cor-
responding to the O-H stretch in ME & EAE 
extracts structure, respectively. Asymmetrical 
stretching (vas CH2) and symmetrical stretch-
ing (vs CH2) of  methylene groups were observed 
in 2925 and 2857 in both extracts, respectively. 
Absorption bands at (1743–1746 cm−1) were con-
tributed to C = O stretching from lactone ester or 
acids in both structures. The bands at 1459 and 
1457 cm−1 corresponded to the C-O-H in plane 
binding of  carboxylic acid (-COOH) in the struc-
ture of  M & EA extracts, respectively. The C = O 
absorption band from acetyl esters was observed 
at 1235 cm−1 in both extracts, while the stretch 
of  the C-O band of  C (-O)-OC in lactones exists 
at 1166 and 1163 cm−1 in M and EA fractions, 
respectively. However, the C-O stretch of  C-O-H 
groups of  sophorose moiety was observed at 1047 
and 1026 cm−1 in both extracts, respectively. The 
IR spectra also revealed the absorption bands 
at 722 - 721 cm−1 for C = C in both M and EA 
extracts, respectively.
The structure of the produced SL compounds 
(M and EA extracts) was assigned to a typical 
glyco-lipid-type structure using 1H NMR spectrum 
analysis. A resonance of two protons for glucose 
molecules was detected in both extracts between 
3.42 to 4.26 ppm. The existence of a fatty acid chain 
was confirmed by the multiple signals between 1.22 
and 1.27 ppm, while the signals from 5.3 to 5.34 
gave the evidence for the existence of a vinyl group 
(-CH = CH-) in both extracts.
The structural characterization of  the produced 
SL extracts was confirmed by the FT-IR and 
1H NMR analyses which was in agreement with 
Rashad et al, (2014 a and b) and Jiménez-Peñalver 
et al. (2016). According to the results of  the FT-IR 
and 1HNMR analyses, all these structural features 
further confirmed the existence of  SL groups in 
the  isolated compounds (acidic and lactone ring 
form).
The presence of  unsaturated fatty acids in 
the SL structure which was proven by the struc-
tural characterization using FTIR and H1 NMR 
could play a role in decreasing plasma cholesterol 
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concentrations. Kris-Etherton and Yu (1997) 
stated that plasma cholesterol concentrations were 
decreased by mono and poly-unsaturated fatty 
acids in clinical experiments. Also Fernandez and 
West (2005) reported that the poly-unsaturated 
fatty acids increase the hepatic LDL-C receptor 
number, LDL-C turnover in vivo and modulate 
VLDL-C metabolism resulting in the reduction of 
the plasma triglycerides level. Thus, with its unsat-
urated fatty acid content and for being a member 
of  the bio-surfactant family which is known to 
have surface and emulsifying activities, SLs were 
expected to have hypocholesterolemic effects. 
Therefore, this study was directed at evaluating the 
effect of  these compounds on lipid metabolism in 
hypercholeterolemic rats.
In the present study, the obtained SL compounds, 
in either of the ME or the EAE were proven to be 
safe and have no acute toxicity effect, as evidenced 
from the data of the LD50 experiment, since no mor-
tality was noticed for any of the tested doses up to 
12 g·Kg−1 mice body weight.
Although the results obtained from this study 
illustrated that some variations occurred in the 
body weight either increased or decreased change 
compared to the negative control negative group, 
none of these changes were significant (Table 2). 
However, there was a significant reduction in food 
intake in the positive control group compared to the 
negative control group. The non-significant reduc-
tion in the body weight gain reported for the con-
trol positive group was in contrast to the results 
obtained by Samarghandian et al. (2011). On the 
other hand, Mohamed et al. (2005) concluded from 
their experiment that non-significant changes were 
observed in body weight gain, while the total food 
intake and food intake/day were significantly lower 
in hypercholesterolemic rats compared to the nor-
mal rats and these results seems to be in accordance 
with our results for both body weight gain and 
food intake. Also, Cha et al. (2016) reported similar 
results for the decreased food intake of the positive 
control group. The decrease in body weight may be 
attributed to the reduction in food intake for the 
Figure 1. FTIR spectra of the isolated sophorolipids compounds (ME & EAE).
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positive control group when compared to the nega-
tive control group. Anyhow, the reduction in both 
food intake and body weight gain returned back to 
the normal values of the negative control group in 
the case of the HFHC groups that received either 
rosuvastatin or EAE. While in case of ME, the 
body weight gain was not only returned to the value 
of the negative control group but, it exceeded this 
value. However, the HFHC group that received the 
mixture of the two extracts showed a slight improve-
ment which was non-significant. The improvement 
in the HFHC group that received EAE is considered 
as a good mark for the positive effect of this extract.
An increase in the liver weight % (hepatosomatic 
index) in all groups that received HFHC was noticed 
which reached up to 49% compared to the negative 
control group (Table 3). This increase can be attrib-
uted to the accumulation of fat, particularly the 
triacylglycerols, in liver tissue as reported by Fassini 
et  al. (2011). As expected, it is obvious that no 
improvement occurred for the hepatosomatic index 
for any of the HFHC groups that received any of the 
treatments (rosuvastatin or the extracts). Although 
all the treatments used either rosuvastatin or the 
extracts had a highly positive effect on plasma lipid 
profile, the liver weight did not return back to its 
normal weight, i. e. there was still an accumulation 
of fat in the liver with the same proportion which 
may be explained on the basis that the liver triacyl-
glycerols needed more time to be removed from the 
liver tissue than did those of the plasma. This expla-
nation seems to be in accordance with the findings 
of Fassini et al. (2011) who reported that the reduc-
tion in liver triacylglycerols of hypercholesterolemic 
rats that received either rosuvastatin or soybean gly-
cinin was slight (still about 3 times as high as that 
of the negative control value) although the reduction 
in plasma triacylglycerols was pronounced. Thus, 
the liver tissue requires more time to be recovered. 
This result was reinforced by the histopathological 
examination (as will be shown later) which revealed 
that there was still steatosis in the liver of the HFHC 
groups that received any of the treatments just as the 
negative control group and no detectable improve-
ment was recorded indicating that the liver needed 
more time to return back to its normal state. Also, 
a significant increase in the kidney weight % was 
observed for the positive control group compared to 
the negative control. However, this increase returned 
back to more or less the normal value of the control 
negative group in the case of the groups that received 
any of the treatments. This improvement was non-
significant compared to the negative control group in 
all treated groups meaning that their values became 
close to that of the negative control group which is 
a good sign and the best result was that recorded for 
the EAE, since it became significantly different from 
the positive control group.
No significant changes were reported for the 
hemoglobin concentration which reflected the safety 
Table 2. Body weight gain, food intake and feed efficiency ratio (FER) of the control group and the different groups
Group Body Weight Gain (g) Food intake (g) FER*
Control (-ve) 30.17 ± 1.99ab 423.33 ± 6.78a 0..071 ± 0.005a
Control (+ve) 18.00 ± 1. 86a 329.33 ± 13.73b 0.057 ± 0.006a
HFHC + Ros 30.00 ± 4.28ab 419.00 ± 9.18a 0.077 ± 0.011a
HFHC + ME 42.14 ± 8.56b 418.57 ± 4.27a 0.069 ± 0.017a
HFHC + EAE 32.00 ± 4.42ab 418.57 ± 12.23a 0.076 ± 0.011a
HFHC + Mix 22.29 ± 2.46a 340.14 ± 10.45b 0.063 ± 0.009a
*FER is calculated as body weight gain / food intake. Values are expressed as mean ± SE and the mean difference is significant at 
P < 0.05. Values that share the same letter (a, b or c) in the same column are not significant while, values that share different letters in 
the same column are significant.
Table 3. Organ weight percent % of the control group and other groups
Group Heart wt. % Liver wt. % Kidney wt. %
Control (-ve) 0.42 ± 0.05a 3.17 ± 0.10a 0.63 ± 0.02a
Control (+ve) 0.40 ± 0.03a 4.62 ± 0.18b 0.73 ± 0.03b
HFHC + Ros 0.43 ± 0.02a 4.28 ± 0.12b 0.67 ± 0.02ab
HFHC + ME 0.43 ± 0.02a 4.60 ± 0.15b 0.67 ± 0.03ab
HFHC + EAE 0.45 ± 0.02a 4.75 ± 0.16b 0.60 ± 0.03a
HFHC + Mix 0.42 ± 0.02a 4.45 ± 0.36b 0.65 ± 0.03ab
*Values are expressed as mean ± SE and the mean difference is significant at P < 0.05. Values that share the same letter (a, b or c) in the 
same column are not significant while, values that share different letters in the same column are significant.
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of the extracts on hemoglobin synthesis (Table 4). 
Glucose concentration was neither altered in the 
positive control group compared to the negative con-
trol nor changed in any of the HFHC groups that 
were given the extracts or rosuvastatin. The non-
significant change in the glucose level in the positive 
control group was also reported by Cha et al. (2016). 
Moreover, a non-significant change was detected 
for both urea and creatinine in all examined groups, 
which reflected the safety of these extracts as well as 
rosuvastatin on the renal tissue.
The liver function represented by the two 
enzymes namely, ALT and AST was affected by the 
induction of  hypercholesterolemia (Table 4). An 
increase in both ALT and AST was observed in the 
positive control group (39.83 ± 2.18 U/L and 56.00 
± 7.50 U/L, respectively) compared to the negative 
control (30.33 ± 2.39 U/L and 32.17 ± 3.17 U/L for 
ALT and AST, respectively). Abreu et al. (2014) 
reported similar results of  increased ALT and AST 
in hypercholesterolemic rats. This increase in the 
present study was significant only in the case of 
AST reaching about twice the value for the nega-
tive control group. The increase in liver enzymes of 
the positive control group may be attributed to the 
disturbances that occurred in the liver tissue due 
to the accumulation of  fat in hepatocytes which 
led to injured hepatocytes, thus affecting their cell 
membrane permeability and leakage of  the hepatic 
enzymes into blood circulation. Bose et al. (2008) 
reported that feeding mice a high-fat diet revealed 
an increase in liver enzymes which is due to the 
high-fat-induced hepatocyte injury. Also, accord-
ing to Pincus and Schaffner (1996), AST and ALT 
are released markedly into serum as a result of 
severe hepato-cellular injury. Ferreira et al. (2015) 
reported similar results for the ALT activity in the 
hypercholesterolemic rats. The increase in the ALT 
activity continued and became significant in case 
of  the HFHC group which was treated with rosu-
vastatin (48.00 ± 2.11 U/L) compared to the nega-
tive control group (30.33 ± 2.39 U/L) indicating a 
negative effect of  rosuvastatin on the liver. This had 
been reported previously by Calderon et al. (2010), 
who stated that the most commonly reported 
adverse effect for statins on the liver is the phenom-
enon known as transaminitis, in which liver enzyme 
levels are elevated in the absence of  any proven 
hepatotoxicity. This condition of  elevated liver 
enzymes due to the use of  statins requires discon-
tinuation of  treatment, leaving a large number of 
at-risk patients untreated. On the other hand, using 
any of  the extracts (either the methanol or the ethyl 
acetate or the mixture of  both of  them) did not 
cause any further increase in the activity of  ALT 
and AST compared to the positive control group. It 
is worth mentioning that the EAE showed a reduc-
tion in the ALT activity (30.67 ± 4.70 U/L) so that 
it returned back to the normal level of  the negative 
control (30.33 ± 2.39 U/L), reflecting the ability of 
this extract to counteract the negative effect of  the 
high-fat diet on the liver tissue and hence decrease 
the high-fat–induced hepatocyte injury. In respect 
to the activity of  AST, the significant increase in 
the positive control group may be explained by 
the fact that this enzyme is not only indicative 
for liver tissue, but also it may be elevated in dis-
eases in other organs such as the heart, pancreas, 
kidney, red blood cells, brain and skeletal muscles 
(Nissen et al., 1965). In this study, hypercholes-
terolemia, with its consequent increased oxidative 
stress, affects many of  these organs as evidenced by 
the histopathology of  liver, kidney, heart and brain 
which will be described later. Consequently, AST 
activity was expected to be markedly elevated due 
to all these involved organs, but, this increase was 
reduced when using either rosuvastatin or any of 
the other extracts, reflecting their ability to amelio-
rate the negative effect of  the high-fat diet on dif-
ferent organs.
A key point in the present study is that the isolated 
SLs were not only able to reduce plasma cholesterol in 
the HFHC fed rats as efficiently as rosuvastatin, but 
were also able to increase the HDL-C fraction (the 
good cholesterol) of these rats while the rosuvastatin 
was not able to do that (Table 5). Also, the isolated 
Table 4. Concentration of hemoglobin and plasma glucose, activities of plasma ALT and AST and concentration of urea and 
creatinine in all groups
Group
Hb
(g/100 mL)
Glucose
(mg/100 mL)
ALT  
(U/L)
AST  
(U/L)
Urea
(mg/100 mL)
Creatinine 
(mg/100 mL)
Control (-ve) 14.55 ± 0.49a 96.07 ± 2.64a 30.33 ± 2.39a 32.17 ± 3.17a 31.90 ± 1.56a 0.62 ± 0.10a
Control (+ve) 14.80 ± 0.25a 93.48 ± 7.97a 39.83 ± 2.18ab 56.00 ± 7.50b 36.45 ± 5.37a 0.51 ± 0.08a
HFHC + Ros 14.03 ± 0.40a 90.39 ± 5.34a 48.00 ± 2.11b 43.50 ± 6.40ab 28.87 ± 2.90a 0.48 ± 0.10a
HFHC + ME 13.77 ± 0.32a 89.21 ± 4.67a 42.00 ± 4.83ab 41.00 ± 4.89ab 31.87 ± 3.45a 0.52 ± 0.09a
HFHC + EAE 13.75 ± 0.72a 100.7 ± 8.31a 30.67 ± 4.70a 48.33 ± 2.45ab 35.12 ± 1.90a 0.72 ± 0.05a
HFHC + Mix 14.82 ± 0.52a 86.10 ± 3.34a 41.00 ± 5.11ab 44.33 ± 5.31ab 31.47 ± 1.61a 0.66 ± 0.07a
*Values are expressed as mean ± SE and the mean difference is significant at P < 0.05. Values that share the same letter (a, b or c) in the 
same column are not significant while, values that share different letters in the same column are significant.
Hypocholesterolemic impact of newly isolated sophorolipids produced by microbial conversion of safflower oil cake • 9
Grasas Aceites 68 (3), July–September 2017, e212. ISSN-L: 0017–3495 doi: http://dx.doi.org/10.3989/gya.0219171
Table 5. Concentration of plasma total cholesterol (TC), triglycerides (TG), HDL-C, LDL-C, VLDL-C and atherogenic index 
(A. I.; log TG/HDL-C) of the control group and all other groups
Group
TC
(mg/100 mL)
TG
(mg/100 mL)
HDL-C
(mg/100 mL)
LDL-C
(mg/100 mL)
VLDL-C
(mg/100 mL) A.I
Control (-ve) 92.10 ± 10.64a 74.22 ± 6.13ab 45.74 ± 0.95a 37.86 ± 7.44a 15.84 ± 0.75 a 0.20 ± 0.04a
Control (+ve) 260.43 ± 31.59c 88.96 ± 3.75b 22.26 ± 2.37b 215.49 ± 32.7c 17.79 ± 0.75ab 0.60 ± 0.05b
HFHC+Ros 126.15 ± 8.18ab 77.68 ± 5.57ab 21.45 ± 0.92b 89.17 ± 8.63b 15.54 ± 1.11abd 0.55 ± 0.05b
HFHC+ME 118.47 ± 9.75ab 64.36 ± 9.08a 41.35 ± 1.8ac 65.95 ± 10.86ab 11.14 ± 0.67cd 0.21 ± 0.07a
HFHC+EAE 107.46 ± 11.0ab 64.60 ± 5.06a 31.99 ± 2.31d 61.92 ± 11.57ab 13.55 ± 0.94cd 0.32 ± 0.03a
HFHC+Mix 151.99 ± 11.25b 61.06 ± 5.69a 38.53 ± 2.40c 101.25 ± 10.9b 13.05 ± 0.80 cd 0.20 ± 0.05a
*Values are expressed as mean ± SE and the mean difference is significant at P < 0.05. Values that share the same letter (a, b, c or d) in 
the same column are not significant while, values that share different letters in the same column are significant.
SLs lowered the increased LDL-C as shown in 
Table 5. Furthermore, the SL extracts reduced the lev-
els of triacylglycerols in the HFHC fed rats more effi-
ciently than rosuvastatin. These differences between 
rosuvastatin and the isolated SLs may be attributed 
to the different mechanisms for their hypocholesterol-
emic action. Rosuvastatin is known to reduce serum 
cholesterol through the inhibition of the very begin-
ning enzyme of the mevalonate pathway; the enzyme 
3-hydroxy-3-methylglutaryl-CoA reductase (HMG-
CoA), which represents the key enzyme in cholesterol 
biosynthesis (Rideout et al., 2010). The isolated com-
pounds in the present study may accelerate the fecal 
excretion of bile acids which increase the demand 
for the synthesis of new bile acids from cholesterol, 
thus decreasing cholesterol levels in the circulation. 
Kuwabara et al. (2007), mentioned that cholesterol 
conversion to bile acids is the major pathway for the 
elimination of cholesterol and represents about 50% 
of daily excretion of cholesterol. Also, the isolated 
SLs may lower the intestinal absorption of cholesterol 
by disturbing the micelle formation which is consid-
ered one of the mechanisms reported for cholesterol 
homeostasis in the body (Srinivasan and Sambaiah, 
1990). The mechanism of action of these isolated SLs 
needs more clarification by further investigation. It is 
worth mentioning that the A.I., which reflects the risk 
for coronary heart disease, was improved in all groups 
that received any of the extracts of the isolated SL 
compounds more efficiently than the rosuvastatin 
and it returned near the normal values of the negative 
control group. On the other hand, the value obtained 
for the rosuvastatin group recorded a slight improve-
ment but still represented a significant increase com-
pared to the negative control group. Based on data 
from the meta-analysis, a 1% decrease in serum cho-
lesterol levels can lower the risk of coronary heart 
disease by up to 3% and a 10% reduction in serum 
cholesterol means a 15% reduction in risk of mortal-
ity from coronary heart disease (Graveline, 2015).
From the present study it can be noticed that 
hypercholesterolemia caused a state of  increased 
oxidative stress evidenced by the significant 
increase in the lipid peroxide product in the posi-
tive control group (Figure 2-A), with a value of 
2.53 ± 0.25 µmol/mL compared to a value for the 
negative control group of  1.69 ± 0.02 µmol/mL. 
This increase was counteracted in all the HFHC 
groups that received either rosuvastatin (1.57 ± 
0.12 µmol/mL) or the extracts (1.78 ± 0.09, 1.81 ± 
0.12 and 1.83 ± 0.08 µmol/mL for ME, EAE and 
Mix groups, respectively) indicating that these 
treatments possess some sort of  antioxidant prop-
erties. In fact, the increased MDA in the hyper-
cholesterolemic rats was reported before by Anila 
and Vijayalakshmi (2003). This can be explained 
by the impact of  the high-fat and high-cholesterol 
diet which induce reactive oxygen species (ROS) 
overproduction which in turn initiates lipid peroxi-
dation as reported by Montilla et al. (2004). Also, 
Oyedemi et al. (2010) reported that HFHC diet 
exerts cytotoxic effects by causing lipid peroxida-
tion resulting in the formation of  MDA. In a trail 
to counteract the increased oxidative stress that 
was induced by hypercholesterolemia, the body’s 
own antioxidant defense system, the antioxidant 
enzymes namely; catalase, GPX and SOD began 
to quench these increased free radicals (Figure 2-B, 
2-C and 2-D, respectively). Then, the excessive uti-
lization of  these enzymes in deactivating the free 
radicals generated by the HFHC diet (Jiangwei 
et al., 2011), resulted in a reduction in the activity 
of  the aforementioned antioxidant enzymes in the 
positive control group. A similar result was reported 
before by Kassem et al. (2011) who mentioned that 
antioxidant enzymes were reduced in rats that were 
fed high-fat and high-cholesterol diets. Introducing 
either rosuvastatin or any of  the extracts restored 
these enzymes. This ameliorative effect may be 
attributed to the antioxidant power possessed by 
the aforementioned treatments which in turn coun-
teracts the overproduction of  the increased ROS, 
thus decreasing the lipid peroxidation and in turn 
normalizing the antioxidant enzymes.
The results of the histopathological examinations 
of different organs (Figures 3–6) such as the liver, the 
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(a) (b) (c)
(d) (e) (f)
Figure 3. Light photomicrographs of livers in rats (a-f). (a) Livers of rats from the negative control group showing the normal 
histological structure of hepatic lobule. (b) Livers of rats from the positive control group showing the hyperplasia of the biliary 
epithelium with fibroplasia in the portal triad, steatosis of hepatocytes and congestion of hepatoportal blood vessels. (c) Livers of 
rats from the hypercholesterolemic group which was given the rosuvastatin showing congestion of the central vein and steatosis of 
hepatocytes. (d) Livers of rats from the hypercholesterolemic group which was given ME showing the steatosis of hepatocytes and 
congestion of the central vein. (e) Livers of rats from the hypercholesterolemic group which was given EAE showing the congestion of 
hepatic sinusoids and the steatosis of hepatocytes. (f) Livers of rats from the hypercholesterolemic group which was given the mixture 
of both methanol and EAE showing the fatty change of focal hepatocytes (H & E X 400).
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Figure 2. A- Concentration of lipid peroxide product; MDA. B- Activity of plasma catalase. C- Activity of RBCs superoxide 
dismutase (SOD). D- Activity of RBCs glutathione peroxidase (GPx) in all groups
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(a) (b) (c)
(d) (e) (f)
Figure 4. Light photomicrographs of  hearts in rats (a-f). (a) Hearts of  rats from the negative control group showing 
normal cardiac myocytes. (b) Hearts of  rats from the positive control group showing the vacuolation of  cardiac myocytes, 
myocarditis,  focal  necrosis  of  cardiac myocytes associated with inflammatory cell infiltration, intermuscular oedema and 
hemorrhage. (c) Hearts of  rats from the hypercholesterolemic group which was given the rosuvastatin showing the focal necrosis 
of  cardiac myocytes associated with inflammatory cell infiltration and intermuscular oedema. (d) Hearts of  rats from the 
hypercholesterolemic group which was given the ME showing few inflammatory cells infiltrating in between cardiac myocytes, the 
congestion of  myocardial blood vessels and inter-muscular oedema. (e) Hearts of  rats from the hypercholesterolemic group which 
was given the EAE showing focal myocarditis, intermuscular inflammatory cell infiltration and intermuscular oedema. (f) Hearts 
of  rats from the hypercholesterolemic group which was given the mixture of  the two extracts showing intermuscular oedema (H 
& E X 400).
(a) (b) (c)
(d) (e) (f)
Figure 5. Light photomicrographs of kidneys in rats (a-f). (a) Kidneys of rats from the negative control group showing the normal 
histological structure of renal parenchyma. (b) Kidneys of rats from the positive control group showing the congestion and atrophy 
of the glomerular tuft with the distension of Bowman’s space, vacuolation of renal epithelium, pyknosis of their nuclei and the 
presence of protein cast in the lumen of renal tubules. (c) Kidneys of rats from the hypercholesterolemic group which was given the 
rosuvastatin showing the congestion of the glomerular tuft. (d) Kidneys of rats from the hypercholesterolemic group which was given 
the ME showing hypertrophy and the congestion of the glomerular tuft and renal blood vessel and the necrosis of the epithelial lining 
of some renal tubules. (e) Kidneys of rats from the hypercholesterolemic group which was given the EAE showing the congestion of 
renal blood vessels. (f) Kidneys of rats from the hypercholesterolemic group which was given the mixture of the two extracts showing 
no histopathological changes (H & E X 400).
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heart, the kidney and the brain were in agreement 
with the results of biochemical markers and even 
reinforced them. Thus, no deterioration in any of 
the examined organs was observed when using any 
of the extracts either the methyl extract or the EAE 
or the mixture of both of them. There was, however, 
an improvement in the kidney and the liver where 
the hyperplasia of biliary epithelium with fibroplasia 
in the portal triad of the liver, which was noticed in 
the positive control group, disappeared. It is worth 
mentioning that all the histopathological changes 
in the kidney that were detected in the positive con-
trol group disappeared in the group of rats that was 
given the mixture of the two extracts. In case of the 
heart and the brain no deterioration was reported for 
the same three groups but a slight improvement was 
recorded compared to the positive control group.
4. CONCLUSION
From the obtained data, it can be concluded that 
the newly isolated SLs, which are of  natural source, 
are potent hypocholesterolemic compounds. The 
obtained extracts of  SLs not only lowered choles-
terol but also adjusted the HDL-C and the LDL-C 
fractions, and lowered the risk for coronary heart 
disease, as documented by the decreased A.I, and 
also normalized the increased activity of  the liver 
enzymes due to hypercholesterolemia better than 
rosuvastatin. In addition, the obtained SLs are 
safe, economical and of  a natural source. However, 
further investigation is needed to determine the 
exact mechanism for lowering the total cholesterol 
and increasing the HDL-C by these extracts. Also, 
trails in human must be carried out in order to 
enable the use of  these compounds as hypocholes-
terolemic drugs.
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